The clinical study to examine efficacies of BSL5-170327C and BSL5-170327S on healthy skin

Trial Profile

The clinical study to examine efficacies of BSL5-170327C and BSL5-170327S on healthy skin

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs BSL5 170327C (Primary)
  • Indications Skin disorders
  • Focus Therapeutic Use
  • Sponsors Kao Corporation
  • Most Recent Events

    • 27 Oct 2017 Status changed from not yet recruiting to completed.
    • 19 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top